Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,806.74 +2,028.95 (+3.28%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
PRTA Sep 2024 15.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:05PM EDT
| Previous close | 1.4000 |
| Open | 1.3500 |
| Bid | 0.5000 |
| Ask | 1.0500 |
| Strike | 15.00 |
| Expiry date | 2024-09-20 |
| Day's range | 1.3500 - 1.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 42 |
Business WireProthena to Report First Quarter 2024 Financial Results on May 8
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
ZacksEarnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
© 2024 Yahoo. All rights reserved.